Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health
Stanford, United States
Brandon Hwa-Lin Bergsneider, from Los Angeles, CA, is pursuing an MD at the Stanford School of Medicine and is a Special Volunteer at the NIH Neuro-Oncology Branch. Brandon earned a BS in human biology from Stanford, and a MSc in bioinformatics and theoretical systems biology from Imperial College London. Brandon aspires to use data science-based technologies to better understand neuro-oncology patients' symptom burden, elucidate predictors of treatment response, and discover novel therapies for brain tumors. At Stanford and Imperial, he researched the molecular bases of neurodegeneration, the genetic susceptibility of neuroblastoma patients to SARS-CoV-2, computational protein structure prediction, and using machine learning to identify chemotherapy-resistant cancer cells. At the NIH, his projects focus on the use of computational network analysis to identify clinical and demographic determinants of brain tumor patient symptom burden. He is a Knight-Hennessy Scholar, a Fulbright Scholar, and an NIH Cancer Research Training Award Fellow.